Azithromycin for Preventing Bronchopulmonary Dysplasia in Extremely Preterm Infants: A Cohort Study
Azithromycin is associated with a reduced risk of grade II<sup>+</sup> BPD in EPIs, likely due to its anti-inflammatory effect.
Authors
- Xueyu Chen (ORCID: https://orcid.org/0000-0002-7066-0501)
- Yali Zeng (ORCID: https://orcid.org/0000-0001-9501-3047)
- Depeng Zhao (ORCID: https://orcid.org/0000-0001-9135-4047)
- Yanqiong Wang
- Binchun Lin
- Zhifeng Huang (ORCID: https://orcid.org/0000-0001-8269-6731)
- Chuanzhong Yang
Institutions
- Shenzhen Maternity and Child Healthcare Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1002/ppul.27384
- Citations
- 1
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- National Natural Science Foundation of China
- Sanming Project of Medicine in Shenzhen